personalized dosing of niraparib in ovarian cancer
Published 3 years ago • 297 plays • Length 3:14Download video MP4
Download video MP3
Similar videos
-
0:58
dr. matulonis on individualized dosing of niraparib in ovarian cancer
-
2:26
dr. mirza discusses niraparib dose modifications for ovarian cancer patients with low body weight
-
3:08
ovarian cancer: optimizing treatment with niraparib
-
2:18
dr. mirza on efficacy of niraparib/bevacizumab combo in recurrent ovarian cancer
-
1:38
dr. chase on niraparib as frontline maintenance therapy in ovarian cancer
-
0:46
dr. chase on toxicities with niraparib in ovarian cancer
-
6:31
prima: frontline niraparib maintenance therapy in ovarian cancer
-
6:25
niraparib maintenance therapy for ovarian cancer
-
5:13
treating ovarian cancer with niraparib: the nova trial
-
1:54
management of niraparib dosing in ovarian cancer
-
1:30
dr. mirza on niraparib efficacy across ovarian cancer subgroups
-
1:50
niraparib shows positive data, requires different dosing in ovarian cancer
-
2:35
dr. monk on choosing between parp inhibitors in ovarian cancer
-
6:20
parp inhibitors in recurrent ovarian cancer
-
1:41
dr. mirza on niraparib plus bevacizumab combo in ovarian cancer
-
1:18
dr. pothuri on patient-reported outcomes with niraparib in advanced ovarian cancer
-
1:14
dr. arend on niraparib with bevacizumab in ovarian cancer
-
0:57
dr. mirza on impact of niraparib in ovarian cancer
-
1:35
dr. secord on personalized treatment in ovarian cancer